TRAVERE THERAPEUTICS

travere-therapeutics-logo

Travere Therapeutics is advancing therapeutic candidates for rare disorders in nephrology, hepatology and metabolism; sponsoring no-cost genetic testing aimed at improving the diagnostic odyssey for children born with cholestasis; partnering with patient advocacy organizations to meet the diverse needs of patients and their families; and ensuring broad access and education for its FDA-approved therapies.
#SimilarOrganizations #People #Financial #Event #Website #More

TRAVERE THERAPEUTICS

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Medical

Founded:
2011-02-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.travere.com

Total Employee:
101+

Status:
Active

Contact:
(646) 564-3680

Email Addresses:
[email protected]

Total Funding:
592.5 M USD

Technology used in webpage:
SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Microsoft Exchange Online Amazon Office 365 Mail


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

edison-pharmaceuticals-logo

Edison Pharmaceuticals

Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.


Current Advisors List

jeffrey-a-meckler_image

Jeffrey A. Meckler Chairman & Member of the Board of Directors @ Travere Therapeutics
Board_member
2014-01-01

suzanne-l-bruhn_image

Suzanne L. Bruhn Board Member @ Travere Therapeutics
Board_member
2020-04-01

ron-squarer_image

Ron Squarer Member Board Of Directors @ Travere Therapeutics
Board_member
2017-04-01

Current Employees Featured

laura-clague_image

Laura Clague
Laura Clague Chief Financial Officer @ Travere Therapeutics
Chief Financial Officer
2014-11-01

stewart-bieler_image

Stewart Bieler
Stewart Bieler Vice President Clinical Operations @ Travere Therapeutics
Vice President Clinical Operations
2019-09-01

john-f-wood_image

John F. Wood
John F. Wood Vice President, Regulatory Affairs @ Travere Therapeutics
Vice President, Regulatory Affairs
2020-11-01

edwin-urrutia_image

Edwin Urrutia
Edwin Urrutia Vice President @ Travere Therapeutics
Vice President
2013-11-01

renato-ray-ramos_image

Renato “Ray” Ramos
Renato “Ray” Ramos Director of Supply Chain and Procurement @ Travere Therapeutics
Director of Supply Chain and Procurement
2017-07-01

noah-rosenberg_image

Noah Rosenberg
Noah Rosenberg Chief Medical Officer @ Travere Therapeutics
Chief Medical Officer
2018-07-01

ian-paterson_image

Ian Paterson
Ian Paterson Senior Director, Global Marketing @ Travere Therapeutics
Senior Director, Global Marketing
2019-08-01

eric-dube_image

Eric Dube
Eric Dube President & Chief Executive Officer @ Travere Therapeutics
President & Chief Executive Officer
2019-01-01

jula-inrig_image

Jula Inrig
Jula Inrig Chief Medical Officer @ Travere Therapeutics
Chief Medical Officer
2022-01-01

Founder


martin-shkreli_image

Martin Shkreli

Stock Details


Company's stock symbol is NASDAQ:TVTX

Acquisitions List

Date Company Article Price
2020-10-22 Orphan Technologies Orphan Technologies acquired by Travere Therapeutics 517 M USD
2014-02-13 Manchester Pharmaceuticals Manchester Pharmaceuticals acquired by Travere Therapeutics N/A

Investors List

athyrium-capital-management_image

Athyrium Capital Management LP

Athyrium Capital Management LP investment in Post-IPO Debt - Travere Therapeutics

athyrium-capital-management_image

Athyrium Capital Management LP

Athyrium Capital Management LP investment in Post-IPO Equity - Travere Therapeutics

Investments List

Date Company Article Money raised
2014-07-31 Perlara Travere Therapeutics investment in Seed Round - Perlara 2.8 M USD

Key Employee Changes

Date New article
2022-01-04 Travere Therapeutics Appoints Jula Inrig, M.D., as Chief Medical Officer

Official Site Inspections

http://www.travere.com Semrush global rank: 1.48 M Semrush visits lastest month: 18.3 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Travere Therapeutics" on Search Engine

dfkcompany.com © 2022. All rights reserved